Researcher.Life Logo

World Allergy Organization Journal : Impact Factor & More

eISSN: 1939-4551pISSN: 1939-4551
JournalOpen Access

Key Metrics

CiteScore
5.8
Impact Factor
5 - 10
SJR
Q3Immunology
SNIP
1.63
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on World Allergy Organization Journal

World Allergy Organization Journal Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Monthly
Article Processing ChargesUSD 2540
Publication Time9
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorWorld Allergy Organization
FrequencyMonthly
Publication Start Year2008
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 9
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in World Allergy Organization Journal ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in World Allergy Organization Journal

Short-term high-dose budesonide nasal spray for postoperative uncontrolled chronic rhinosinusitis: A randomized controlled trial
  • 1 May 2026
  • World Allergy Organization Journal
Efficacy predictions for omalizumab treatment based on basophil CD203c expression in patients with allergic rhinitis by basophil activation test -- a real-life, pilot study.
  • 1 May 2026
  • The World Allergy Organization journal
Overview of allergic disease: Pathogenesis of allergic inflammation - WAO White Book on Allergy 2026 - 2.1.
  • 1 May 2026
  • The World Allergy Organization journal
Real-life lessons on omalizumab and food allergy: The potential for unexplored outcomes.
  • 1 May 2026
  • The World Allergy Organization journal
Prevalence and risk factors of asthma, rhinoconjunctivitis and eczema in the very extreme environment of Naryn, Kyrgyzstan.
  • 1 May 2026
  • The World Allergy Organization journal
Corrigendum to "Retrospective analysis of the efficacy and safety of 100 mg abrocitinib in patients with moderate to severe atopic dermatitis: Real-world study" [World Allergy Organ J 16 (2) (2023) 101167
  • 1 May 2026
  • The World Allergy Organization journal
Short-term high-dose budesonide nasal spray for postoperative uncontrolled chronic rhinosinusitis: A randomized controlled trial
  • 1 May 2026
  • World Allergy Organization Journal
Efficacy predictions for omalizumab treatment based on basophil CD203c expression in patients with allergic rhinitis by basophil activation test -- a real-life, pilot study.
  • 1 May 2026
  • The World Allergy Organization journal
Overview of allergic disease: Pathogenesis of allergic inflammation - WAO White Book on Allergy 2026 - 2.1.
  • 1 May 2026
  • The World Allergy Organization journal
Real-life lessons on omalizumab and food allergy: The potential for unexplored outcomes.
  • 1 May 2026
  • The World Allergy Organization journal
Prevalence and risk factors of asthma, rhinoconjunctivitis and eczema in the very extreme environment of Naryn, Kyrgyzstan.
  • 1 May 2026
  • The World Allergy Organization journal
Corrigendum to "Retrospective analysis of the efficacy and safety of 100 mg abrocitinib in patients with moderate to severe atopic dermatitis: Real-world study" [World Allergy Organ J 16 (2) (2023) 101167
  • 1 May 2026
  • The World Allergy Organization journal

FAQs on World Allergy Organization Journal